7 results
Thrombotic Microangiopathy - TTP VS HUS

Big picture points : Often hard to differentiate the two entities,
Thrombotic Microangiopathy ... #Thrombotic #Microangiopathy ... #thrombocytopenic ... Comparison #Diagnosis #Table ... #Hematology
Thrombotic Microangiopathies - Primary Thrombotic Microangiopathy (TMA) - Differential Diagnosis Table

 • Thrombotic Thrombocytopenic Purpura (TTP)
Primary Thrombotic Microangiopathy ... Differential Diagnosis Table ... • Thrombotic Thrombocytopenic ... Primary #Thrombotic #Microangiopathy ... #TMA #hematology
Approach to Thrombotic Microangiopathy (TMA) - Differential Diagnosis and Management Algorithm

Suspected TMA: Unexplained thrombocytopenia + MAHA
to Thrombotic Microangiopathy ... and Management Algorithm ... TMA: Unexplained thrombocytopenia ... #Thrombotic #Microangiopathy ... #hematology
Thrombotic Microangiopathy - TMAs
1. Not all MAHAs are due to TMAs but (almost) all TMAs cause
Thrombotic Microangiopathy ... triad of MAHA + thrombocytopenia ... APS, SRC, SLE), cancer ... #Thrombotic #Microangiopathy ... #TMAs #hematology
Causes of Anemia with Normal Mean Corpuscular Volume (MCV) - Differential Diagnosis Algorithm
Decreased WBCs
 - Decreased/NormaI
Differential Diagnosis Algorithm ... Fragments • Microangiopathic ... Inflammation • Cancer ... Differential #Diagnosis #Algorithm ... #Causes #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... the treatment of cancer-associated ... thrombosis; PE = pulmonary ... #Algorithm #Anticoagulation ... #Management #Hematology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... From Blood Cancer ... cardiovascular or pulmonary ... #algorithm #hematology ... #cancer